|
|
Volumn 301, Issue 14, 2009, Pages 1423-1424
|
|
Rare neurological condition linked to newer monoclonal antibody biologics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EFALIZUMAB;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NATALIZUMAB;
RITUXIMAB;
IMMUNOLOGIC FACTOR;
AUTOIMMUNE DISEASE;
CROHN DISEASE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNE RESPONSE;
INFECTION;
INFLAMMATION;
MULTIPLE SCLEROSIS;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
NOTE;
RISK ASSESSMENT;
ANTIBODIES, MONOCLONAL;
HUMANS;
IMMUNOLOGIC FACTORS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
RISK ASSESSMENT;
|
|
EID: 64249145021
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.451 Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|